Investigation Overview
An investigation on behalf of investors, who currently hold shares of Aratana Therapeutics, Inc. (NASDAQ: PETX), was announced concerning whether the takeover of Aratana Therapeutics, Inc.. is unfair to NASDAQ: PETX stockholders. The investigation by a law firm concerns whether certain officers and directors of Aratana Therapeutics, Inc. breached their fiduciary duties owed to NASDAQ...
You must register (for free) or login to view the entire investigation.